FAM
PACB icon

Fred Alger Management’s Pacific Biosciences PACB Stock Holding History

Fred Alger Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-62,105
Closed -$609K – 483
2023
Q4 		$609K Buy
+62,105
New +$508K ﹤0.01% 384
2023
Q3 		– Sell
-69,780
Closed -$928K – 511
2023
Q2 		$928K Buy
+69,780
New +$848K ﹤0.01% 380
2018
Q4 		– Sell
-180,000
Closed -$974K – 558
2018
Q3 		$974K Buy
+180,000
New +$772K ﹤0.01% 324
2016
Q4 		– Sell
-10,000
Closed -$90K – 510
2016
Q3 		$90K Buy
+10,000
New +$83.6K ﹤0.01% 384

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.39B AUM 10.34% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Fred Alger Management's PACB Position: Q1 2024 in Review

Fred Alger Management sold out of Pacific Biosciences (PACB) in Q1 2024, closing a stake of 62,105 shares — an estimated $609K sold.

Fred Alger Management first reported a position in PACB in Q3 2016 and held it in 4 quarters. The position peaked at $974K in Q3 2018. 268 funds tracked by Wall St. Rank hold PACB as of Q1 2024.

  • Fred Alger Management reported no remaining Pacific Biosciences position as of Q1 2024 after selling out during the quarter.
  • Fred Alger Management sold 62,105 Pacific Biosciences shares in Q1 2024, an estimated $609K.
  • Fred Alger Management first reported a position in Pacific Biosciences in Q3 2016 and held it in 4 quarters.
  • Fred Alger Management's Pacific Biosciences position peaked at $974K in Q3 2018.
  • 268 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2024.

Based on Fred Alger Management's 13F filing for Q1 2024, filed 15 May 2024.